Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Active Biotech on real estate transaction
Mandate

Vinge advises Active Biotech on real estate transaction

March 14, 2019 M&A

Active Biotech AB (publ) has entered an agreement regarding sale of the property Forskaren 1 in Lund, to an investor collective led by the real estate company Estea AB. The purchase price amounts to SEK 275 million. The transaction is subject to the general meeting’s approval. 

Vinge advises Active Biotech. Vinge’s team is primarily composed of Erik Sjöman, Anna Edström, Christian Lindhé and Jessica Salomonsson. 

Related

Vinge advises The Qt Company Ltd on its public offer for I.A.R. Systems Group AB (publ)

The Qt Company Ltd (“The Qt Company”), a wholly owned subsidiary of Qt Group Plc, has announced a public tender offer to the shareholders of I.A.R. Systems Group AB (publ) (“IAR”) to tender all class B shares in IAR to The Qt Company at a price of SEK 180 in cash per share
July 04, 2025

Vinge has advised Consolid on the establishment of Consolid Equity III

 The fund held its final closing on June 2, 2025, having secured commitments from a diverse investor base that includes several leading institutional investors from Europe and North America, as well as established fund-of-funds. The fundraising was highly successful, with the fund significantly oversubscribed. Consolid Equity III has more than doubled its total commitments compared to its predecessor fund.
July 02, 2025

Vinge advises EQT VIII in connection with the divestment of Recover to Pangea AS

 Recover is a leading Scandinavian property remediation specialist. Following EQT’s acquisition in 2020, Recover has invested in its digital capabilities while divesting non-core business units to sharpen focus on water, fire and other core property remediation services.
July 02, 2025